|
Composition: Croscarmellose sodium, Microcrystalline cellulose (PH 102), Talc, Colloidal Silicon Dioxide (Aerosil 200), Magnesium Stearate. Capsule cap composition (Opaque white): Titanium dioxide, Gelatin. Capsule body composition (Opaque white): Titanium dioxide, Gelatin. Indications: Neuropathic pain QUEENLEPT is indicated for the treatment of peripheral neuropathic pain in adults, Epilepsy QUEENLEPT is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalization. Generalised Anxiety Disorder QUEENLEPT is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults. 4.2. Posology and method of administration. The dose range is 150 to 600 mg per day given in either two or three divided doses. QUEENLEPT may be taken without food. Dosages and administration:
|
 |
||||||||||||||||||||||||||||||||